Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma Kas 17, 2025 System Admin Healthcare
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US Kas 17, 2025 System Admin Healthcare
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline Kas 17, 2025 System Admin Healthcare
RCSI Medical University of Bahrain Strengthens Clinical Excellence Collaboration with the Royal College of Physicians of Ireland Kas 17, 2025 Beatriz Escanilla Healthcare
Tree-Planting and Health Awareness Campaign Launched in Al-Mina District, Hodeidah Kas 17, 2025 Beatriz Escanilla Healthcare
MOH workshop aims to strengthen Kuwait’s e-Health Info System Kas 17, 2025 Beatriz Escanilla Healthcare
